08:30 - 09:00

Program Registration

09:00-09:45

Welcome
Ela Bochenek, Seton Hall Law School (New Jersey)

09:45-10:40

Aligning the “Why” and “How” of Compliance
Professor Timothy Glynn, Seton Hall Law School (New Jersey)

10:40-11:00

Break

11:00-12:30

Global Anti-Corruption Enforcement
Wilson Ang, Norton Rose Fulbright (Singapore)
Carol Ann Poindexter, Norton Rose Fulbright (Washington, D.C.)
Paul Sumilas, Norton Rose Fulbright (Singapore)

12:30-13:30

Lunch

13:30-14:40

Being the Focus of a Government Investigation
Yuet Ming Tham, Sidley Austin LLP (Hong Kong/Singapore)

14:40-15:00

Break

15:00-16:30

Data Analytics
Lem Chin Kok, KPMG (Singapore)

08:45

Sign-In

09:00-09:10

Key Concept Review & Corruption Quiz
Professor Timothy Glynn, Seton Hall Law School (New Jersey)

09:10-10:25

Anti-Corruption Settlements
Eric Carlson, Covington & Burling (Shanghai)

10:25-10:50

Break

10:50-11:55

Focus on China
Eric Carlson, Covington & Burling (Shanghai)

11:55-13:00

Competition Law in the Health Care Sector
Hwa-Soo Chung, Kim & Chang (Seoul)
Yunjoh Lee, Kim & Chang (Seoul)

13:00-14:00

Lunch

14:00-15:05

Global and Regional Industry Codes (Pharma & Device)
Hwa-Soo Chung, Kim & Chang (Seoul)
Yunjoh Lee, Kim & Chang (Seoul)

15:05-15:25

Break

15:25-16:25

ASIA Transparency Trends & Challenges
Speaker TBA

16:25-17:45

Compliance Officers Panel Discussion
Masood Ahmed, Sanofi Group (Singapore)
Maija Burtmanis, Shire
Ronald Goon, Johnson & Johnson (Singapore)
Benjamin Kwak, Zimmer (Singapore)
Moderator: Professor Timothy Glynn, Seton Hall Law School (New Jersey)

17:45-19:30

Networking Reception for All Program Faculty & Attendees

08:45

Sign-In

09:00-10:00

Emerging Risk Area: Patient Programs
Maija Burtmanis, Shire BioPharma – Asia Pacific (Japan)

10:00-10:15

Break

10:15-12:00

Interactive Case Study Session
Maija Burtmanis, Shire BioPharma – Asia Pacific (Japan)

12:00-13:00

Lunch

13:00-14:00

Assessing Third Party Risk
Masood Ahmed, Sanofi Group (Singapore)

14:00-15:10

Health Care in India: Regulatory Compliance – Prevention is Better Than a Cure
Dr. Milind Antani, Nishith Desai Associates (Mumbai)

15:10-15:20

Break

15:20-17:30

Interactive Session
Prof. Timothy Glynn, Seton Hall Law School (New Jersey)
Ela Bochenek, Seton Hall Law School (New Jersey)

08:45

Sign-In

09:00-10:00

Data Protection Risks as Related to Anti-Corruption Compliance, Mergers & Acquisitions, and Internal Investigations
Ken Chia, Baker & McKenzie, Wong & Leow (Singapore)

10:00-10:45

Building an Effective Compliance Program & Team
Stephanie Chew, Edwards Lifesciences (Shanghai)

10:45-11:15

Break

11:15-12:00

How To Be Recognized as a Trusted Compliance Professional
Young Sang Kwon, Johnson & Johnson (Singapore)

12:00-13:00

Lunch

13:00-13:30

Interactive Session – Part 1 Teamwork: evaluate proposed activities, assess business & legal risk, and develop recommendations
Teamwork

13:30-15:30

Interactive Session - Part 2 Team Presentations & Classroom Discussion
Ronald Goon, Johnson & Johnson (Singapore)

15:30-16:00

Closing Remarks and Awarding of Program Certificates